Current Data

U.S. Cannabis Spot Index up 0.8% to $1,098 per pound.

The simple average (non-volume weighted) price decreased $28 to $1,151 per pound, with 68% of transactions (one standard deviation) in the $405 to $1,897 per pound range. The average reported deal size was nominally unchanged at 2.8 pounds. In grams, the Spot price was $2.42 and the simple average price was $2.54.

The relative frequency of trades for indoor flower decreased by 3%. The relative frequency of transactions involving greenhouse and outdoor product increased by 2% and 1%, respectively. The relative volumes of each grow type were unchanged compared to last week. In the four major Western markets, small shifts in each product type’s share of the reported weight moved were observed, with warehouse flower seeing slight increases in its relative volume in most of the states in question.    

The U.S. Spot Index rose by 0.8% this week to settle at $1,098 per pound. In what was for the most part uncharacteristic post-4/20 behavior, the Spot Indices of the five largest adult-use markets – California, Colorado, Oregon, Washington, and Nevada – all saw increases in their composite prices. Last year, only Colorado and Oregon experienced upticks in their Spot rates in the week subsequent to 4/20; of the five states under discussion, only Colorado did in 2017. Also notable this week were significant declines documented in the Spot Indices of several sizeable medical cannabis systems, among them Arizona, Massachusetts, Michigan, and New Mexico. While the increased demand associated with 4/20 is typically discussed in regard to adult-use markets, data from some medical programs such as Arizona has shown that patients take advantage of the “holiday” to stock up, which can depress demand subsequently.  

The national volume-weighted price for flower to be sold in adult-use markets rose this week on increases in Colorado, Oregon, Washington State, and Nevada. California also saw a week-over-week downturn in its adult-use sector. Falling prices for medical product in Arizona, Massachusetts, Illinois, Michigan, and New Mexico were primarily responsible for pulling down the national rate for flower to be sold to patients.